Black raspberries fuel new oral cancer drug
Regulatory Affairs Associates (RAA) has signed a contract with Ohio State University to manufacture clinical supplies for a new drug designed to prevent oral cancer. The topical gel formulation uses anthocyanins obtained from black raspberries as the active component. Anthocyanins are promising cancer-preventing agents due to their antioxidant and anti-inflammatory properties. After harvesting black raspberries, the cancer-preventing compounds in the fruit are concentrated and freeze dried. Laboratory experiments and pilot

